BackCinCor Pharma Overview

CinCor Pharma Current Cash

Latest current cash for CINC: $290M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$292.56M
↑ 106.45% YoYΔ $150.85M vs prior year quarter

Peer trimmed avg / median

Loading

CinCor Pharma Current Cash History

Loading

CinCor Pharma vs. peers: Current Cash Comparison

Loading

CinCor Pharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CinCor Pharma (CINC) FAQ

As of the most recent data (September 2022), CINC shows a current cash of $290M. That compares with $140M in the prior-year period — up 106.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CINC's current cash is now $290M (was $140M) — a 106.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether CinCor Pharma is outperforming or lagging.

Tracking CINC's current cash over time shows whether CinCor Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $290M That compares with $140M in the prior-year period — up 106.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has CinCor Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $290M) with ownership activity and broader fundamentals.